Advancing PROTACs, molecular glues, and next-generation proximity-based therapeutics with enhanced safety and drug-like properties to drive clinical translation and unlock previously undruggable targets across oncology and wider disease areas.
The 6th TPD & Induced Proximity Summit Europe is Europe’s definitive meeting dedicated to proximity-based drug discovery. Showcasing innovations spanning PROTACs, molecular glues, stabilizers, and extracellular degraders, it highlights therapeutic advances across oncology, neurodegeneration, immunology, and rare diseases. Taking place in London in March 2026, the summit convenes over 80 CxOs, directors, senior scientists, and investors to drive the progression of proximity-based therapeutics from early discovery through to clinical translation.
View Event
